Here's Why You Should Consider Buying Pro-Dex (PDEX) Shares
Long Cast Advisers, an investment management firm, released its third quarter 2023 investor letter, a copy of which can be downloaded here.
Stay updated with breaking news from Dex Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Long Cast Advisers, an investment management firm, released its third quarter 2023 investor letter, a copy of which can be downloaded here.
StockNews.com started coverage on shares of Pro-Dex (NASDAQ:PDEX – Free Report) in a report published on Tuesday. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Stock Up 5.3 % Shares of PDEX opened at $18.63 on Tuesday. The firm has a market cap of $66.14 million, a PE ratio of […]
StockNews.com started coverage on shares of Pro-Dex (NASDAQ:PDEX – Free Report) in a report issued on Monday. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Stock Down 1.8 % Shares of Pro-Dex stock opened at $17.06 on Monday. The company has a debt-to-equity ratio of 0.28, a current ratio of […]
Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock ...
StockNews.com began coverage on shares of Pro-Dex (NASDAQ:PDEX – Free Report) in a research note published on Sunday. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Stock Performance NASDAQ:PDEX opened at $17.05 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.58 and a current […]